Gonadotropin-releasing hormone analogue (GnRH-A) induces multiple ovulations of high-quality eggs in a cold-water, batch-spawning teleost, the yellowtail flounder (Pleuronectes ferrugineus)

1997 ◽  
Vol 54 (9) ◽  
pp. 1957-1964 ◽  
Author(s):  
DGJ Larsson ◽  
C C Mylonas ◽  
Y Zohar ◽  
L W Crim

Sustained delivery systems for a gonadotropin-releasing hormone analogue (GnRH-A) were used for the first time in a cold-ocean teleost for inducing multiple ovulations. Intramuscular implants of 75-224 µg/kg GnRH-A ((D-Ala6,Pro9-NHEt)LHRH) were administered to female yellowtail flounder (Pleuronectes ferrugineus) either as a cholesterol pellet or as biodegradable microspheres. Females implanted with GnRH-A ovulated 3-4 weeks earlier than controls, producing multiple batches of high-quality eggs (average rates of fertilization 66-68% and hatching 55-60%); control fish eggs had significantly lower fertilization (39%) and hatching rates (25%). GnRH-A treatment doubled the egg production, synchronized the females, and shortened the interovulatory periods. The proportion of round, clear, and floating eggs lacking a perivitelline space before fertilization was an indicator of the fertilization (r2 = 0.60) and hatching (r2 = 0.56) success. Moreover, egg collections of less than 10 mL varied greatly in quality, whereas larger batches, generally promoted by GnRH-A, consisted of relatively high-quality eggs. GnRH-A treated fish had increased plasma levels of estradiol-17 beta 4 days after implantation. A model for prediction of the time between hormone treatment and first spawning (T; days) was developed using the initial follicle diameter (D; µm) as the only predictor (T = 365(D - 380)-0.82; r2 = 0.91).

2021 ◽  
Vol 34 (4) ◽  
pp. 479-484
Author(s):  
Piyathida Wijarn ◽  
Preamrudee Poomthavorn ◽  
Patcharin Khlairit ◽  
Sarunyu Pongratanakul ◽  
Laor Chailurkit ◽  
...  

Abstract Objectives To determine appetite-regulating hormone levels in girls with central precocious puberty (CPP) before and after 20 weeks of gonadotropin-releasing hormone analogue (GnRH-A) treatment. Methods Eighteen newly diagnosed CPP girls were enrolled. Body composition measured by bioelectrical impedance analysis and GnRH-A test were performed with fasting serum leptin, ghrelin and peptide YY (PYY) measurements at baseline (before) and after 20 weeks of GnRH-A treatment. Results Following GnRH-A treatment, all patients had prepubertal gonadotropin and estradiol levels. Mean (SD) fat mass index (FMI) was significantly increased from 4.5 (1.7) to 5.0 (1.8) kg/m2 after treatment. Also, median (IQR) serum leptin level was significantly increased from 6.9 (4.2–8.6) to 7.4 (5.3–13.1) ng/mL. FMI had a positive correlation with serum leptin level (r=0.64, p=0.004). In contrast, no significant changes of serum ghrelin and PYY levels were observed. Conclusions Decreased estrogen following short-term GnRH-A treatment in CPP girls may cause an increase in appetite and consequently an elevation of FMI. Increased serum leptin may be a result of having increased FMI secondary to an increase in appetite.


Sign in / Sign up

Export Citation Format

Share Document